Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020
October 28, 2020 at 08:59 am EDT
Share
Beijing Leadman Biochemistry Co.,Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 324.788 million compared to CNY 361.817 million a year ago. Operating income was CNY 38.558 million compared to CNY 31.562 million a year ago. Net income was CNY 4.997 million compared to CNY 10.765 million a year ago. Basic earnings per share from continuing operations was CNY 0.012 compared to CNY 0.026 a year ago.
Beijing Leadman Biochemistry Co., Ltd is a China-based company principally engaged in the research, development, production and sales of in-vitro diagnostic reagents. Its diagnostic reagents include chemiluminescence diagnostic reagents and biochemical diagnostic agents, such as hepatitis B virus attributes and tumor markers. The Company also produces diagnostic instruments and biochemical raw materials. Its diagnostic instruments include automatic luminescence immunity analyzers, among others. Its products are applied in various fields, including liver diseases, kidney diseases, cardiovascular diseases, immunological diseases and diabetes, among others. The Company mainly operates businesses in domestic market.
BEIJING LEADMAN BIOCHEMISTRY CO.,LTD. 
